Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 19;10(1):e004034. doi: 10.1136/jitc-2021-004034

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

TCR-based lineage tracing showing CD8 +TILs differentiation in MOC22 tumors with anti-PD1 treatment. (A) Diffusion pseudotime of indicated CD8 +T cell subsets in different treatment conditions. ****p<0.0001. Significance was calculated by two-tailed Student’s t-test.) (B) Heatmap of TCR clone size in MOC22 tumors. Cells were colored by TCR clone size on a log2 scale in the UMAP of T cells in indicated conditions. (C) Shared fraction analysis heatmaps of TCR clonotypes between primary and secondary phenotypes in indicated conditions of MOC22. MOC, murine oral carcinoma; TILs, tumor infiltrating lymphocytes.